Elekta receives FDA nod

Swedish radiation oncology firm Elekta has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Volumetric Intensity Modulated Arc Therapy (VMAT) technology.

VMAT will be available via the company's Synergy digital linear accelerator offering, according to the Stockholm-based firm.

Related Reading

Elekta launches virtual clinic, June 13, 2008

Elekta wins Louisiana radiotherapy contract, June 5, 2008

Elekta receives Australian order, May 2, 2008

Elekta readies first order for New Zealand, April 25, 2008

Elekta completes CMS purchase, March 5, 2008

Copyright © 2008 AuntMinnie.com

Page 1 of 461
Next Page